Your browser doesn't support javascript.
loading
Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy.
Gaffney, Kelly J; Davis, James A; McGann, Mary; Edwards, Kathy; Ahmed, Zaheer; Butcher, Colleen; Greenwell, Brian; Hess, Brian T; Hashmi, Hamza.
Afiliação
  • Gaffney KJ; Medical University of South Carolina, Charleston, SC, USA.
  • Davis JA; Medical University of South Carolina, Charleston, SC, USA.
  • McGann M; Medical University of South Carolina, Charleston, SC, USA.
  • Edwards K; Medical University of South Carolina, Charleston, SC, USA.
  • Ahmed Z; Medical University of South Carolina, Charleston, SC, USA.
  • Butcher C; Medical University of South Carolina, Charleston, SC, USA.
  • Greenwell B; Medical University of South Carolina, Charleston, SC, USA.
  • Hess BT; Medical University of South Carolina, Charleston, SC, USA.
  • Hashmi H; Medical University of South Carolina, Charleston, SC, USA.
J Oncol Pharm Pract ; 30(1): 151-158, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37097891
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Corticosteroides Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Corticosteroides Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article